Diabetology Ltd
From Wikipedia, the free encyclopedia
| Diabetology Ltd | |
|---|---|
| Type | Private |
| Founded | November 2002 |
| Headquarters |  Saint Helier, Jersey |
| Key people | Roger New (CSO) Glen Travers |
| Industry | Biotechnology |
| Products | 2 in clinical development and 3 in pre-clinical development |
| Website | www.diabetology.co.uk |
Diabetology Ltd is a biopharmaceutical company based in Saint Helier, Jersey.
It was founded in November 2002 and is developing oral drugs for the treatment of diabetes mellitus.
[edit] Products
Currently the company doesn't have a marketed product, though its pipeline includes one drug that has recently completed phase II clinical development, one in phase II clinical development, and three in pre-clinical development[1].
| Drug | Phase | Action |
|---|---|---|
| Capsulin OAD | Phase II clinical trial completed | Oral insulin for diabetes mellitus type 2 |
| Capsulin IR | Phase II clinical trial | Oral insulin for diabetes mellitus type 1 |
| Combulin | Pre-clinical development | Oral combination of insulin and insulin sensitizing agents for diabetes mellitus type 2 |
| Oral GLP-1 | Pre-clinical development | Improves glycaemic and diet control in diabetes mellitus type 2 |
| Oral C-Petdide | Pre-clinical development | Reduces diabetic complications |
[edit] References
[edit] External links
 |
This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |
